Indivior Pharmaceuticals annual gross margin
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Gross Margin Growth & History (INDV)
Indivior Pharmaceuticals's gross margin was 80.23% for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 80.23% | −0.33 pp |
| 2024 | 2024-12-31 | 80.56% | −3.52 pp |
| 2023 | 2023-12-31 | 84.08% | +0.95 pp |
| 2022 | 2022-12-31 | 83.13% | −0.81 pp |
| 2021 | 2021-12-31 | 83.94% | — |
Indivior Pharmaceuticals quarterly gross margin
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 85.71% | +2.93 pp |
| Q1 2026 | 2026-03-31 | 87.38% | +4.30 pp |
| Q4 2025 | 2025-12-31 | 82.07% | −1.82 pp |
| Q3 2025 | 2025-09-30 | 73.25% | −5.25 pp |
| Q2 2025 | 2025-06-30 | 82.78% | +9.20 pp |
| Q1 2025 | 2025-03-31 | 83.08% | −3.54 pp |
| Q4 2024 | 2024-12-31 | 83.89% | — |
| Q3 2024 | 2024-09-30 | 78.50% | — |
| Q2 2024 | 2024-06-30 | 73.58% | — |
| Q1 2024 | 2024-03-31 | 86.62% | — |
Indivior Pharmaceuticals gross margin trends
Across the available reported history, Indivior Pharmaceuticals's gross margin decreased from 80.56% to 80.23%, a change of −0.33 percentage points. The latest reported quarter, Q2 2026, shows 85.71%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals filings at SEC.gov ↗